| 1 |
Rosa Casado Portilla |
Reform Biologics |
4 |
| 2 |
Dmitriy V. Ivashin |
Implant Sciences |
3 |
| 3 |
Humberto de la Vega |
Agrivida |
2 |
| 3 |
Scott D. Arena |
Verizon |
2 |
| 3 |
Scott Louis Cohen |
Novartis Ag |
2 |
| 3 |
Kellie Haley |
Thermo Fisher |
2 |
| 3 |
Stephen Richard Moreschi |
Skyworks Solutions |
2 |
| 3 |
Ralph Weissleder |
The General Hospital |
2 |
| #9 |
Jeffery J. Serre |
Osram Sylvania |
1 |
| #9 |
Ryan Fuchs |
Unknown |
1 |
| #9 |
Fanglei Zhuang |
New England Biolabs |
1 |
| #9 |
William Brown |
The Gillette Company |
1 |
| #9 |
Trevor Squier |
Semprus Biosciences |
1 |
| #9 |
Christopher K. Olsen |
Tel Epion |
1 |
| #9 |
Joshua Laverdiere |
— |
1 |
| #9 |
Robert Patrick Tameo |
GE |
1 |
| #9 |
Piotr Lubicki |
Varian Semiconductor Equipment Associates |
1 |
| #9 |
Stanley Michael Marcinkowski |
The Gillette Company |
1 |
| #9 |
Gregory M. Fagerlund |
RTX (Raytheon) |
1 |
| #9 |
Daniel Faken |
Coventor |
1 |
| #9 |
Nathan Roth |
Alza |
1 |
| #9 |
Brendan LaBrecque |
Foster-Miller |
1 |
| #9 |
Richard C. Bellofatto, Jr. |
Gem Co. |
1 |
| #9 |
Karyn Kelley |
Emc Ip Holding Company |
1 |
| #9 |
Thomas Richard |
A.W. Chesterton |
1 |
| #9 |
Charles Shaughnessy |
Analogic |
1 |
| #9 |
Giovanni Lepore |
Teledyne Flir |
1 |